Plus Therapeutics, Inc.
PSTV
$0.2025
-$0.1061-34.38%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 173.63% | -24.69% | -43.24% | 161.63% | -62.31% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.78% | 12.15% | -39.05% | -4.45% | -5.45% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.83% | -- | -- | -- | -- |
| Total Current Assets | 106.66% | -1.96% | -42.81% | 122.64% | -57.16% |
|
|
|||||
| Total Current Assets | 106.66% | -1.96% | -42.81% | 122.64% | -57.16% |
| Net Property, Plant & Equipment | -30.52% | -25.25% | -19.98% | -10.30% | -12.36% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -7.25% | -8.58% | -7.90% | 1,587.88% | -21.43% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 58.33% | -62.50% | 0.00% | 0.00% | 0.00% |
| Total Assets | 81.76% | -4.94% | -37.76% | 99.47% | -50.64% |
|
|
|||||
| Total Accounts Payable | -2.66% | 19.74% | 13.91% | 7.74% | 35.50% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 0.00% | 0.00% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.09% | -35.29% | -26.09% | -97.52% | -9.55% |
| Total Finance Division Other Current Liabilities | 39.91% | 10.36% | -90.07% | 3,323.89% | -- |
| Total Other Current Liabilities | 39.91% | 10.36% | -90.07% | 3,323.89% | -- |
| Total Current Liabilities | -32.10% | 28.39% | -35.53% | 80.66% | -3.06% |
|
|
|||||
| Total Current Liabilities | -32.10% | 28.39% | -35.53% | 80.66% | -3.06% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 0.00% | 0.00% | -- | -- |
| Capital Leases | -- | -22.50% | -20.00% | -15.25% | -30.59% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 129.09% | 28.23% | -35.49% | 80.12% | -17.89% |
|
|
|||||
| Common Stock & APIC | 0.56% | 0.03% | 1.11% | 0.03% | 0.03% |
| Retained Earnings | -3.53% | -0.80% | -0.59% | -0.61% | -0.68% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | -296.83% |
| Total Common Equity | -164.17% | -72.96% | 32.14% | -57.64% | -258.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -164.17% | -72.96% | 32.14% | -57.64% | -258.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -164.17% | -72.96% | 32.14% | -57.64% | -258.83% |
|
|
|||||